Physician profile
David B Smith
NPI 1023002375
$1,087.66
in general payments reported to CMS, 2019-2025
18 companies · $188 in 2025
The $188 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $291 · 2020: $248 · 2022: $45.46 · 2023: $224 · 2024: $91.39 · 2025: $188.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $504.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $503.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $236.50 | 2019-2020 | |
| Boston Scientific Corporation | $106.56 | 2020 | |
| Pacira Pharmaceuticals Incorporated | $101.02 | 2025 | Exparel |
| Bayer Healthcare Pharmaceuticals INC. | $98.28 | 2022-2025 | |
| Allergan, INC. | $92.09 | 2019-2020 | |
| Hologic Sales and Service, LLC | $75.52 | 2019-2024 | Myosure Tissue Removal Device, Fluent Fluid Management System, Aptima |
| Abbvie INC. | $74.50 | 2019-2023 | Liletta, Lo Loestrin Fe |
| Ethicon US, LLC | $73.28 | 2023 | Enseal |
| Mayne Pharma Commercial LLC | $71.30 | 2023-2025 | |
| Evofem Biosciences, INC. | $35.13 | 2023 | Phexxi |
| Aspira Women'S Health INC | $20.05 | 2024 | Ova1 |
| Millicent US INC | $16.26 | 2019 | |
| Merck Sharp & Dohme LLC | $15.79 | 2024 | Bridion |
| Sumitomo Pharma America, INC. | $15.76 | 2023 | Myfembree |
| Medtronic, INC. | $15.16 | 2024 | Sonicision |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exeltis, USA INC. | $15.02 | 2023 | Slynd |
| Avion Pharmaceuticals | $13.95 | 2019 | |
| Lupin INC. | $11.49 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.